PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 15, 1998Cancer135 citationsOpen Access

Cause of death in men diagnosed with prostate carcinoma

View Full Paper
WSWilliam A. SatarianoKRKathleen RaglandSEStephen K. Van Den Eeden

Key Points

  • To evaluate specific causes of death among men diagnosed with prostate carcinoma and assess how mortality causes vary by age, race, disease stage, and comorbidity.
  • Reviewed medical records of decedent health plan members diagnosed with prostate carcinoma between January 1980 and December 1984 (N=584).
  • Evaluated demographic factors, symptoms, stage, treatments, and computerized discharge summaries for comorbid conditions using multivariable logistic regression.
  • Approximately 54% of the decedent prostate carcinoma cohort died directly from their prostate cancer.
  • Dying from prostate carcinoma was significantly more likely among decedents who were Black, aged ≤65 years, diagnosed at an advanced stage, treated with hormonal therapy, or survived >6 months post-diagnosis.
  • Dying from non-prostate causes was independently associated with concurrent cardiovascular disease after adjusting for race, age, and stage.

Abstract

BACKGROUND: Prostate carcinoma is one of the leading causes of death in men. Although the mortality rate is high, it still may underestimate the number of deaths associated with the disease. This study was conducted to compare causes of death among men previously diagnosed with prostate carcinoma and to examine the extent to which differences in cause of death (death from prostate carcinoma vs. death from other causes) varied by age, race, clinical factors, and comorbid conditions. METHODS: A review was conducted of the medical records of decedent members of the Kaiser Permanente Medical Care program who previously were diagnosed with prostate carcinoma between January 1980 and December 1984 (n=584). The review focused on demographic factors, symptoms, diagnostic tests, stage of disease, and treatment. Data on comorbidity were obtained from a computerized discharge summary. Logistic regression analysis was used to estimate odds ratios. RESULTS: Approximately 54% of the decedent prostate carcinoma patients died of their prostate carcinoma. Decedents who were black, age 6 months after diagnosis were more likely than others to die of prostate carcinoma. In contrast, the likelihood of dying of some other cause was associated with concurrent cardiovascular disease, after adjustment for the effects of race, age, and disease stage. There also were significant two-way age-race and age-time-to-death interactions. CONCLUSIONS: The prognostic significance of cardiovascular disease in prostate carcinoma patients should be investigated in subsequent survival studies. A number of questions need to be addressed delineating the complex relations between coexisting diseases and their treatment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Satariano et al. (1998) studied this question.

synapsesocial.com/papers/6a19a6277081f56b37dee201https://doi.org/10.1002/(sici)1097-0142(19980915)83:6<1180::aid-cncr18>3.0.co;2-1
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Coronary Artery Revascularization and the Risk of Death in Men With Prostate Cancer2011
  2. 2Abstract TP183: Dual burden of Prostate cancer and Stroke in US Men Aged 55 and Older: Insights from Multiple Cause of Death Data2026
  3. 3Mortality trends and disparities in prostate cancer with co-occurring cardiometabolic disorders among U.S. men aged ≥ 55 years, 1999–2024.2026
  4. 4Rising mortality related to cardiovascular disease and prostate cancer amongst older men across the United States2024 · 9 citations
  5. 5Non-cancer causes of death in patients with hormone-sensitive prostate cancer.2026